These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24785948)

  • 1. Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.
    van Teijlingen NH; Hölzemer A; Körner C; García-Beltrán WF; Schafer JL; Fadda L; Suscovich TJ; Brander C; Carrington M; Evans DT; van Baarle D; Altfeld M
    AIDS; 2014 Jun; 28(10):1399-408. PubMed ID: 24785948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.
    Fadda L; Körner C; Kumar S; van Teijlingen NH; Piechocka-Trocha A; Carrington M; Altfeld M
    PLoS Pathog; 2012; 8(7):e1002805. PubMed ID: 22807681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.
    Hölzemer A; Thobakgale CF; Jimenez Cruz CA; Garcia-Beltran WF; Carlson JM; van Teijlingen NH; Mann JK; Jaggernath M; Kang SG; Körner C; Chung AW; Schafer JL; Evans DT; Alter G; Walker BD; Goulder PJ; Carrington M; Hartmann P; Pertel T; Zhou R; Ndung'u T; Altfeld M
    PLoS Med; 2015 Nov; 12(11):e1001900; discussion e1001900. PubMed ID: 26575988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    Ziegler MC; Naidoo K; Chapel A; Nkotwana S; Mann J; Mncube Z; Ismael N; Goulder P; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS; 2021 Jan; 35(1):151-154. PubMed ID: 33273184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
    Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
    EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable Frequencies of HLA-C
    Ziegler MC; Grañana FB; Garcia-Beltran WF; Schulze Zur Wiesch J; Hoffmann C; Rechtien A; Lunemann S; Altfeld M
    Front Immunol; 2018; 9():2361. PubMed ID: 30386333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C
    Lin Z; Kuroki K; Kuse N; Sun X; Akahoshi T; Qi Y; Chikata T; Naruto T; Koyanagi M; Murakoshi H; Gatanaga H; Oka S; Carrington M; Maenaka K; Takiguchi M
    Cell Rep; 2016 Nov; 17(9):2210-2220. PubMed ID: 27880898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
    Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
    Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
    Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
    Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
    J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
    Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
    J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.
    Lunemann S; Martrus G; Hölzemer A; Chapel A; Ziegler M; Körner C; Garcia Beltran W; Carrington M; Wedemeyer H; Altfeld M
    J Hepatol; 2016 Aug; 65(2):252-8. PubMed ID: 27057987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.
    Sim MJ; Malaker SA; Khan A; Stowell JM; Shabanowitz J; Peterson ME; Rajagopalan S; Hunt DF; Altmann DM; Long EO; Boyton RJ
    Front Immunol; 2017; 8():193. PubMed ID: 28352266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
    Cassidy S; Mukherjee S; Myint TM; Mbiribindi B; North H; Traherne J; Mulder A; Claas FH; Purbhoo MA; Das J; Khakoo SI
    Eur J Immunol; 2015 Feb; 45(2):492-500. PubMed ID: 25359276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased HLA-C1 alleles in couples of KIR2DL2 positive women with recurrent pregnancy loss.
    Yang X; Yang E; Wang WJ; He Q; Jubiz G; Katukurundage D; Dambaeva S; Beaman K; Kwak-Kim J
    J Reprod Immunol; 2020 Nov; 142():103186. PubMed ID: 32846355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide antagonism as a mechanism for NK cell activation.
    Fadda L; Borhis G; Ahmed P; Cheent K; Pageon SV; Cazaly A; Stathopoulos S; Middleton D; Mulder A; Claas FH; Elliott T; Davis DM; Purbhoo MA; Khakoo SI
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10160-5. PubMed ID: 20439706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.